Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Centre hospitalier de l'Université de Montréal (CHUM)
Seagen Inc.
AstraZeneca
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Eli Lilly and Company
Pfizer
Genmab
Tomsk National Research Medical Center of the Russian Academy of Sciences
Pusan National University Hospital
Jonsson Comprehensive Cancer Center
University of California, Davis
Arcus Biosciences, Inc.
University Hospital Heidelberg
University Hospital Heidelberg
M.D. Anderson Cancer Center
AstraZeneca
M.D. Anderson Cancer Center
City of Hope Medical Center
AstraZeneca
Memorial Sloan Kettering Cancer Center
Abramson Cancer Center at Penn Medicine
Memorial Sloan Kettering Cancer Center
Amgen
M.D. Anderson Cancer Center
University of California, Davis
H. Lee Moffitt Cancer Center and Research Institute
Replimune Inc.
Johannes Gutenberg University Mainz
City of Hope Medical Center
Carevive Systems, Inc.
University of Pennsylvania
City of Hope Medical Center
M.D. Anderson Cancer Center
Pfizer
Providence Health & Services
VA Office of Research and Development
M.D. Anderson Cancer Center
Ohio State University Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Mayo Clinic